Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 41 - 50 of 112

Selected Filters:
3 November 2022

MATRIX Project Overview

This factsheet provides an overview of USAID’s Microbicide Research and Development to Advance HIV Prevention Technologies through Responsive Innovations and Excellence (MATRIX) project.

Community/Advocacy, Research

Document
27 September 2022

PEP needs some pep! Addressing PEP Neglect in HIV Prevention Research, Programming and Uptake

Recording / Slides / Resources PEP, post-exposure-prophylaxis, is an HIV prevention intervention marked by both great promise and profound neglect. It is useful in both occupational and non-occupational contexts – yet uptake, especially in non-occupational contexts – is poor in most places on the planet. Our panel will unpack the issues and offer research, policy,…

Community/Advocacy

Event
16 September 2022

Engaging HIV-Prevention Ambassadors to Promote Oral PrEP among Adolescent Girls and Young Women: Results of a Zimbabwe field test

This article from the African Journal of AIDS Research describes the results of a field test of the HIV Prevention Ambassador Training Package for Adolescent Girls and Young Women, a toolkit designed to improve skills, knowledge, and attitudes about oral PrEP among peer ambassadors.

Community/Advocacy, Demand Creation/Marketing, Research

External Link
13 September 2022

Healthy Markets for Global Health: A Market Shaping Primer

This primer from USAID presents the state of practice of global market shaping to advance health goals by identifying noteworthy achievements across products and markets. It is intended for global health decision makers and technical health experts.

Community/Advocacy, Demand Creation/Marketing, Financing & Costing, Service Delivery, Supply Chain Management

Document
1 September 2022

Blazing a trail for MPT counseling: Efforts to develop recommendations for the Dual Prevention Pill and reconcile inconsistent guidance for delivering PrEP and oral contraception

This poster from AIDS 2022 describes a process for future efforts to develop appropriate counseling guidance for Multipurpose Technologies, based on learnings from the Dual Prevention Pill and using missed pills as an illustrative example.

Community/Advocacy, Service Delivery

Document
1 September 2022

How Market Preparation for the Dual Prevention Pill is Reimagining Prevention Programs for a Future with MPTs

This slide deck presentation from AIDS 2022 describes how prevention programs can prepare for multipurpose prevention technology (MPTs) such as the Dual Prevention Pill, which combines protection against pregnancy and HIV, and offers marketing insights. The session also presents recommendations for provider counseling on a combined product. Watch the full session from AIDS 2022 here.

Community/Advocacy, Service Delivery

Presentation
1 September 2022

Including Pregnant and Lactating Populations in HIV Prevention Research

For prevention options to meet the real life circumstances of the people who need them, we need an inclusive research agenda. Advocacy for the inclusion of pregnant and lactating populations (PLP) in research has been gaining traction in recent years. This page has a library of resources that provide background on the issue, update on…

Community/Advocacy, Research

External Link
15 August 2022

By women, for women: A story of rings, research and resolve

This dynamic photo story from the International Partnership for Microbicides explains how the dapivirine vaginal ring was conceived, and the journey it has taken to becoming an HIV prevention choice for women.

Community/Advocacy, Research

External Link
12 August 2022

A Plan for Accelerating Access and Introduction of Injectable CAB for PrEP

AVAC’s Plan for Accelerating Access and Introduction of Injectable Cabotegravir (CAB) for PrEP provides a comprehensive view of all the moving parts involved in delivering this new PrEP option and identifies priorities for ensuring time is not wasted and opportunity is not squandered. The plan focuses on learning the lessons from the first ten years…

Community/Advocacy

External Link
4 August 2022

AVAC, BMGF, CIFF, MedAccess, Unitaid and ViiV Healthcare announce collaboration to catalyse more affordable access to long- acting injectable cabotegravir for HIV prevention

AVAC press release announcing a new collaboration focused on pricing, innovative funding mechanisms, tracking regulatory approvals, and ensuring the inclusion of civil society in key planning and decision making to speed access to injectable cabotegravir (CAB) for PrEP. Launched at the 24th International AIDS Conference, this collaboration includes AVAC, the Bill and Melinda Gates Foundation,…

Community/Advocacy

External Link